Sign up to save your podcasts
Or
Share Biggest Risks (and Possible Rewards) of AI in Clinical Data
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biggest Risks (and Possible Rewards) of AI in Clinical Data
Are we any closer to working out the human-machine relationship needed to embed AI in clinical development?
To discuss this and all things automation, Veeva’s Chief Technology Officer Drew Garty joins host Manny Vazquez as he kicks off the new season with two innovators in the industry: Doug Bain, founder and consulting partner at Clinflo, and Robert Bergann, clinical digital innovation leader at Bayer.
Recorded at R&D and Quality Summit 2025 in Madrid.
View all episodes
By Veeva Systems
5
88 ratings
Are we any closer to working out the human-machine relationship needed to embed AI in clinical development?
To discuss this and all things automation, Veeva’s Chief Technology Officer Drew Garty joins host Manny Vazquez as he kicks off the new season with two innovators in the industry: Doug Bain, founder and consulting partner at Clinflo, and Robert Bergann, clinical digital innovation leader at Bayer.
Recorded at R&D and Quality Summit 2025 in Madrid.
More shows like Unblinded: A Clinical Trial Podcast
View all
Consider This from NPR
6,450 Listeners
Good Hang with Amy Poehler
12,951 Listeners